Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05156580
Other study ID # 2021-P2-163-01
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date July 1, 2016
Est. completion date September 1, 2026

Study information

Verified date August 2023
Source Beijing Friendship Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The present study aimed to investigate the impact of obesity on long-term cardiovascular risk in elderly patients with hypertension.


Description:

Overweight status and obesity are important risk factors leading to hypertension, poor blood pressure control, and poor prognosis. However, the studies focused on elderly patients with hypertension are limited. Therefore, the aim of the present study was to evaluate the long-term impact of obesity on cardiovascular risk in elderly patients with hypertension.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 10750
Est. completion date September 1, 2026
Est. primary completion date July 1, 2026
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 60 Years and older
Eligibility Inclusion Criteria: - Ages of = 60 years - History of hypertension and treatment with anti-hypertension drugs for more than 4 weeks - Availability for follow-up until 2026 - No major barriers to provide written consent Exclusion Criteria: - NA

Study Design


Related Conditions & MeSH terms


Intervention

Other:
No intervention
This is an observational study without any intervention

Locations

Country Name City State
China Beijing Friendship Hospital, Capital Medical University Beijing Beijing

Sponsors (2)

Lead Sponsor Collaborator
Beijing Friendship Hospital Beijing Tongzhou Yongshun Community Health Service

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Percentage of participants with major adverse cardiovascular events (MACEs) Percentage of participants with major adverse cardiovascular events (MACEs), including all-cause death, nonfatal myocardial infarction (MI), nonfatal stroke and coronary revascularization. 2021-2026
Secondary Percentage of participants with all-cause death Percentage of participants with cardiovascular, non-cardiovascular and undetermined death. 2021-2026
Secondary Percentage of participants with MI Percentage of participants with fatal and nonfatal MI. 2021-2026
Secondary Percentage of participants with stroke Percentage of participants with fatal and nonfatal stroke. 2021-2026
Secondary Percentage of participants undergoing coronary revascularization Percentage of participants undergoing ischemia- and non-ischemia-driven coronary revascularization. 2021-2026
Secondary Change in BP control rate Change in BP control rate (office BP: SBP < 140 mmHg and DBP < 90 mmHg) from baseline to follow-up. 2021-2026
Secondary Change in SBP Change in SBP from baseline to follow-up. 2021-2026
Secondary Change in estimated glomerular filtration rate (eGFR) Change in estimated glomerular filtration rate (eGFR) in ml/min/1.73m2 from baseline to follow-up. 2021-2026
Secondary Change in low-density lipoprotein-cholesterol (LDL-c) Change in low-density lipoprotein-cholesterol (LDL-c) in mmol/L from baseline to follow-up. 2021-2026
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2